K. van Rhee

Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study

P. D. van der Linden, C. Knibbe, E. Krekels, 2022, Clinical Pharmacokinetics.

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals

P. Pickkers, J. van Paassen, Q. de Mast, 2021, International Journal of Antimicrobial Agents.

Chloroquine for treatment of COVID-19 - a pig in a poke?

P. Pickkers, J. van Paassen, Q. de Mast, 2020, medRxiv.

Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study

P. D. van der Linden, C. Knibbe, E. Krekels, 2022, Clinical Pharmacokinetics.

Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

S. Geerlings, R. V. van Hest, P. D. van der Linden, 2022, The Journal of antimicrobial chemotherapy.